J&J expects jump in COVID vaccine sales in 2022, eyes device deals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Johnson & Johnson (JNJ) PT Raised to $163 at Goldman Sachs
January 26, 2022 7:36 AM ESTGoldman Sachs analyst Chris Shibutani raised the price target on Johnson & Johnson (NYSE: JNJ) to $163.00 (from $161.00) while maintaining a Neutral rating.
... More